A prospective study on dual time 18F-FDG-PET/CT in high-risk prostate cancer patients

BMC Res Notes. 2018 Dec 7;11(1):871. doi: 10.1186/s13104-018-3985-2.

Abstract

Objective: This proof of concept study investigated whether dual time point FDG-PET/CT with image acquisition after 1 and 3 h could be useful in preoperative staging of patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection for high-risk prostate cancer.

Results: Twenty patients with high-risk prostate cancer underwent dual time point FDG-PET/CT before undergoing surgery. Histologically confirmed lymph node metastases were found in 9/20 (45%). A median of 19 (range 10-41; n = 434) lymph nodes were removed per patient. Pelvic lymph nodes with detectable FDG uptake were seen in two patients only, but the FDG-avid lesion on PET did not correspond with pathological findings in either patient. We found a significant increase in maximal standardized uptake value of the prostate of around 30% between early and late imaging. We found no correlation between clinical findings after radical prostatectomy and PET measurements.

Keywords: Diagnostic imaging; Fluorodeoxyglucose; Positron emission tomography; Prostatic neoplasms.

MeSH terms

  • Aged
  • Fluorodeoxyglucose F18 / chemistry*
  • Humans
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography*
  • Postoperative Care
  • Prospective Studies
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / surgery
  • Risk Factors
  • Time Factors

Substances

  • Fluorodeoxyglucose F18